Bausch & Lomb (BLCO) shares drop 9% after Blackstone (BX) may withdraw from bidding for the eyecare company due to high price ...

Four years on from weighing a bid to buy Dexus, there has been talk that global private equity powerhouse Blackstone has been ...

Analysts fell to the sidelines weighing in on StepStone Group (STEP – Research Report) and Blackstone Group (BX – Research Report) with neutral ...

Blackstone-backed IGI India's IPO to raise ₹4,225 crore, focusing on lab-grown diamond certification for global markets.

Mitsubishi Chemical has hired Goldman Sachs to run the sale process and binding bids are due on Dec. 24, the sources said ...

Blackstone (NYSE: BX), the world’s leading alternative investment firm, today announced that Real Estate funds managed by Blackstone (“Blackstone”) have entered into definitive agreements to acquire ...

Blackstone-backed diamond grading firm's IPO opens, raising ₹1,900 crore from anchor investors, with a price band of ₹397-417 ...

In a report released today, Jeff Bernstein from Barclays maintained a Hold rating on Blackstone Group (BX – Research Report), with a price ...

Bausch + Lomb’s board — which includes hedge fund titan John Paulson and a representative of activist investor Carl Icahn, who are both major Bausch Health shareholders — had been hoping for an offer ...

CCI approves Blackstone's acquisition of stakes in Bagmane Developers and Bagmane Rio, marking a significant move in the ...

Blackstone Inc. signaled that it’s eager to strengthen its relationship with Nippon Life Insurance Co. following the Japanese firm’s $8.2 billion purchase of Resolution Life Group Holdings Ltd.